The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease

To investigate the clinical features of parenchymal neuro-Behcet’s disease (p-NBD), we retrospectively reviewed the medical records of 1009 BD patients admitted to Peking Union Medical College Hospital from 2000 to 2016. Forty-two patients (25 males and 17 females) with p-NBD and eighty-four age- an...

Full description

Bibliographic Details
Main Authors: Dong Yan, JinJing Liu, Yuehua Zhang, Wei Yuan, Yan Xu, Jing Shi, Chaoran Li, Yining Wang, Linyi Peng, Yunjiao Yang, Jiaxin Zhou, Di Wu, Zhichun Liu, Xiaofeng Zeng, Fengchun Zhang, Wenjie Zheng, Yan Zhao
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2019/7371458
id doaj-4f69d2fa4a57407f83c3777bf4f0b877
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Dong Yan
JinJing Liu
Yuehua Zhang
Wei Yuan
Yan Xu
Jing Shi
Chaoran Li
Yining Wang
Linyi Peng
Yunjiao Yang
Jiaxin Zhou
Di Wu
Zhichun Liu
Xiaofeng Zeng
Fengchun Zhang
Wenjie Zheng
Yan Zhao
spellingShingle Dong Yan
JinJing Liu
Yuehua Zhang
Wei Yuan
Yan Xu
Jing Shi
Chaoran Li
Yining Wang
Linyi Peng
Yunjiao Yang
Jiaxin Zhou
Di Wu
Zhichun Liu
Xiaofeng Zeng
Fengchun Zhang
Wenjie Zheng
Yan Zhao
The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease
Journal of Immunology Research
author_facet Dong Yan
JinJing Liu
Yuehua Zhang
Wei Yuan
Yan Xu
Jing Shi
Chaoran Li
Yining Wang
Linyi Peng
Yunjiao Yang
Jiaxin Zhou
Di Wu
Zhichun Liu
Xiaofeng Zeng
Fengchun Zhang
Wenjie Zheng
Yan Zhao
author_sort Dong Yan
title The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease
title_short The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease
title_full The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease
title_fullStr The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease
title_full_unstemmed The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease
title_sort clinical features and risk factors of parenchymal neuro-behcet’s disease
publisher Hindawi Limited
series Journal of Immunology Research
issn 2314-8861
2314-7156
publishDate 2019-01-01
description To investigate the clinical features of parenchymal neuro-Behcet’s disease (p-NBD), we retrospectively reviewed the medical records of 1009 BD patients admitted to Peking Union Medical College Hospital from 2000 to 2016. Forty-two patients (25 males and 17 females) with p-NBD and eighty-four age- and sex-matched BD patients without neurological involvement who were served as controls were enrolled. Neurological onset was concomitant with the onset of BD in six cases (14.3%). Pyramidal signs (50.0%) and headache (33.3%) were the most common manifestations. On MRI, the lesions were mainly in the midline structures and hyperintense in the T2-weighted image. The most common lesion was the brainstem (54.8%). Spinal cord involvement was observed in five cases, four of which with cervical cord involvement. Multifocal lesions were observed in 13 patients. Ocular involvement was more prevalent in p-NBD (35.7%) (P=0.041, OR=2.36, 95% CI=1.03-5.44) compared with controls. All patients received corticosteroids and immunosuppressants, mainly cyclophosphamide (39/42). Six patients with severe/refractory condition received biological agents and achieved response measured by decreased Rankin score (P=0.002). With a median follow-up of 28 months, 22 patients (61.1%) achieved clinical improvements, while 10 (27.8%) relapsed and 4 died (mortality rate 11.1%). p-NBD is a rare yet disabling and life-threatening complication of BD. Ocular involvement is a risk factor for p-NBD. Promptly aggressive treatment is essential for improving prognosis, and biological agents might be a promising approach for severe/refractory p-NBD.
url http://dx.doi.org/10.1155/2019/7371458
work_keys_str_mv AT dongyan theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT jinjingliu theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT yuehuazhang theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT weiyuan theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT yanxu theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT jingshi theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT chaoranli theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT yiningwang theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT linyipeng theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT yunjiaoyang theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT jiaxinzhou theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT diwu theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT zhichunliu theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT xiaofengzeng theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT fengchunzhang theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT wenjiezheng theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT yanzhao theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT dongyan clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT jinjingliu clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT yuehuazhang clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT weiyuan clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT yanxu clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT jingshi clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT chaoranli clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT yiningwang clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT linyipeng clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT yunjiaoyang clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT jiaxinzhou clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT diwu clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT zhichunliu clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT xiaofengzeng clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT fengchunzhang clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT wenjiezheng clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
AT yanzhao clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease
_version_ 1724932708645208064
spelling doaj-4f69d2fa4a57407f83c3777bf4f0b8772020-11-25T02:06:40ZengHindawi LimitedJournal of Immunology Research2314-88612314-71562019-01-01201910.1155/2019/73714587371458The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s DiseaseDong Yan0JinJing Liu1Yuehua Zhang2Wei Yuan3Yan Xu4Jing Shi5Chaoran Li6Yining Wang7Linyi Peng8Yunjiao Yang9Jiaxin Zhou10Di Wu11Zhichun Liu12Xiaofeng Zeng13Fengchun Zhang14Wenjie Zheng15Yan Zhao16Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Oncology and Immunology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, ChinaDepartment of Rheumatology, Kailuan General Hospital, Hebei United University, Tangshan 063000, ChinaDepartment of Neurology, Peking Union Medical College Hospital, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Radiology, Peking Union Medical College Hospital, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaTo investigate the clinical features of parenchymal neuro-Behcet’s disease (p-NBD), we retrospectively reviewed the medical records of 1009 BD patients admitted to Peking Union Medical College Hospital from 2000 to 2016. Forty-two patients (25 males and 17 females) with p-NBD and eighty-four age- and sex-matched BD patients without neurological involvement who were served as controls were enrolled. Neurological onset was concomitant with the onset of BD in six cases (14.3%). Pyramidal signs (50.0%) and headache (33.3%) were the most common manifestations. On MRI, the lesions were mainly in the midline structures and hyperintense in the T2-weighted image. The most common lesion was the brainstem (54.8%). Spinal cord involvement was observed in five cases, four of which with cervical cord involvement. Multifocal lesions were observed in 13 patients. Ocular involvement was more prevalent in p-NBD (35.7%) (P=0.041, OR=2.36, 95% CI=1.03-5.44) compared with controls. All patients received corticosteroids and immunosuppressants, mainly cyclophosphamide (39/42). Six patients with severe/refractory condition received biological agents and achieved response measured by decreased Rankin score (P=0.002). With a median follow-up of 28 months, 22 patients (61.1%) achieved clinical improvements, while 10 (27.8%) relapsed and 4 died (mortality rate 11.1%). p-NBD is a rare yet disabling and life-threatening complication of BD. Ocular involvement is a risk factor for p-NBD. Promptly aggressive treatment is essential for improving prognosis, and biological agents might be a promising approach for severe/refractory p-NBD.http://dx.doi.org/10.1155/2019/7371458